However, we found no significant difference in the level of antibody/antibodies that bound to the PD2 peptoid in the PD patients vs. NC subjects using both serum IgG level and serum total protein level to standardize the serum volume used in the enzyme-linked immunosorbent assay (ELISA). This evidence concerns the gene PAF1 and Parkinson disease.